Comparing decisions for malaria testing and presumptive treatment: A net health benefit analysis

Medical Decision Making

Volumn 34, Issue 8, 2014, Pages 996-1005

  Basu, Sanjay ^a   Modrek, Sepideh ^a   Bendavid, Eran ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Artemisinin based combination therapy; Health care costs; Malaria; Mathematical model; Presumptive treatment; Rapid diagnostic tests

Indexed keywords

ANTIMALARIAL AGENT;

AFRICA; COMPARATIVE STUDY; DECISION MAKING; HUMAN; MALARIA; PUBLIC HEALTH; TRANSMISSION;

AFRICA; ANTIMALARIALS; DECISION MAKING; HUMANS; MALARIA; PUBLIC HEALTH;

EID: 84908202079     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X14533609     Document Type: Article

References (45)

1. Basu S, Andrews J, Kishore S, Panjabi R, Stuckler D. Comparative performance of private and public healthcare systems in low and middle-income countries: a systematic review. PLoS Med. 2012;9(6):e1001244.
2. Reyburn H. New WHO guidelines for the treatment of malaria. BMJ. 2010;340:c2637. Available from: URL: http://www.bmj.com/content/340/bmj.c2637
3. D'Acremont V, Lengeler C, Mshinda H, Mtasiwa D, Tanner M, Genton B. Time to move from presumptive malaria treatment to laboratory-confirmed diagnosis and treatment in African children with fever. PLoS Med. 2009;6(1):e252.
4. World Health Organization. World Malaria Report 2011. Geneva: World Health Organization; 2011.
5. Fidock DA. Eliminating malaria. Science. 2013;340(6140):1531-3.
6. Cohen JM, Woolsey AM, Sabot OJ, Gething PW, Tatem AJ, Moonen B. Optimizing investments in malaria treatment and diagnosis. Science. 2012;338(6107):612-4.
7. World Health Organization. Guidelines for the Treatment of Malaria. Geneva: World Health Organization; 2010.
8. English M, Reyburn H, Goodman C, Snow RW. Abandoning presumptive antimalarial treatment for febrile children aged less than five years - a case of running before we can walk? PLoS Med. 2009;6(1):e1000015.
9. Tougher S, Ye Y, Amuasi JH, et al. Effect of the Affordable Medicines Facility-malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet. 2012;380(9857):1916-26.
10. Health Action International. Retail Prices of ACTs Co-paid by the AMFm and Other Antimalarial Medicines. Den Dolder, the Netherlands: Overtoom HAI; 2012.
11. White MT, Conteh L, Cibulskis R, Ghani AC. Costs and cost-effectiveness of malaria control interventions-a systematic review. Malar J. 2011;10:337.
12. Breman JG, Alilio MS, Mills A, Russell S. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome. 2004. Available from: URL: http://www.ncbi.nlm.nih.gov/books/NBK3768/
13. Shepard DS, Ettling MB, Brinkmann U, Sauerborn R. The economic cost of malaria in Africa. Trop Med Parasitol Off Organ Dtsch Tropenmedizinische Ges Dtsch Ges Tech Zusammenarbeit GTZ. 1991;42(3):199.
14. Chima RI, Goodman CA, Mills A. The economic impact of malaria in Africa: a critical review of the evidence. Health Policy. 2003;63(1):17-36.
15. Roll Back Malaria. Economic costs of malaria. World Health Organization. Available from: URL: http://www.rbm.who.int/cmc-upload/0/000/015/363/RBMInfosheet-10.htm
16. Packard RM. Roll back malaria, roll in development? Reassessing the economic burden of malaria. Popul Dev Rev. 2009;35(1):53-87.
17. Kelly-Hope LA, McKenzie FE. The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Malar J. 2009;8(1):19.
18. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994;72(3):429.
19. Murray CJ, Jamison DT, Lopez AD, Ezzati M, Mathers CD. Global Burden of Disease and Risk Factors. Washington, DC: World Bank and Oxford University Press; 2006. Available from: URL: https://openknowledge.worldbank.org/handle/10986/7039
20. Nonvignon J, Chinbuah MA, Gyapong M, et al. Is home management of fevers a cost-effective way of reducing under-five mortality in Africa? The case of a rural Ghanaian District. Trop Med Int Health. 2012;17(8):951-7.
21. Snow RW, Craig MH, Newton CR, Steketee RW. The public health burden of Plasmodium falciparum malaria in Africa. Working Paper 11. Bethesda, MD: Disease Control Priorities Project; 2003. Available from: URL: http://archives.who.int/prioritymeds/report/append/610snow-wp11.pdf
22. Tufts University. CEA Registry Website. 2013. Available from: URL: https://research.tufts-nemc.org/cear4/default.aspx
23. Murray C, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197-223.
24. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996;276(15):1253-8.
25. Koella JC, Antia R. Epidemiological models for the spread of anti-malarial resistance. Malar J. 2003;2(1):3.
26. Aron JL, May RM. The population dynamics of malaria. In: Anderson RM. The Population Dynamics of Infectious Diseases: Theory and Applications. London: Chapman Hall; 1982. p 139-79.
27. Okell LC, Drakeley CJ, Bousema T, Whitty CJM, Ghani AC. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med. 2008;5(11):e226.
28. Pitman R, Fisman D, Zaric GS, et al. Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force-5. Value Health. 2012;15(6):828-34.
29. Kirkpatrick S, Gelatt CD, Vecchi MP. Optimization by simulated annealing. Science. 1983;220:671-80.
30. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med. 1999;5(3):340-3.
31. Snow RW, Omumbo JA, Lowe B, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet. 1997;349(9066):1650-4.
32. United Nations. World Population Prospects: The 2012 Revision. >Geneva: United Nations; 2013.
33. Abba K, Deeks JJ, Olliaro PL, et al. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev. 2011;(7):CD008122. Available from: URL: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008122.pub2/abstract
34. Bender R. Number needed to treat (NNT). Encycl Biostat. 2005. Available from: URL: http://onlinelibrary.wiley.com/doi/10.1002/0470011815.b2a04032/full
35. Stinnett AA, Mullahy J. Net health benefits a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18(2):S68-S80.
36. Basu S, Chapman GB, Galvani AP. Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets. Proc Natl Acad Sci U S A. 2008;105:19018-23.
37. Durham DP, Mbah MLN, Medlock J, et al. Dengue dynamics and vaccine cost-effectiveness in Brazil. Vaccine. 2013. Available from: URL: http://www.sciencedirect.com/science/article/pii/S0264410X13008141
38. Jamison DT, Breman JG, Measham AR, et al. Intervention costeffectiveness: overview of main messages. 2006. Available from: URL: http://www.ncbi.nlm.nih.gov/books/NBK11784/
39. President's Malaria Initiative. AMFm and PMI's Commitment to Global Efforts to Ensure Prompt Malaria Diagnosis and Treatment. Washington, DC: Clinton Health Access Initiative; 2011.
40. National Malaria Control Programme, suMAP, World Health Organization and Malaria Public Health Department (Kenya). A Description of the Epidemiology of Malaria to Guide the Planning of Control in Nigeria. Nairobi, Kenya: Federal Ministry of Health, Nigeria; 2013.
41. Stern DI, Gething PW, Kabaria CW, et al. Temperature and malaria trends in highland east Africa. PLoS ONE. 2011;6(9):e24524.
42. Snow RW, Amratia P, Kabaria CW, Noor AM, Marsh K. The changing limits and incidence of malaria in Africa: 1939-2009. Adv Parasitol. 2012;78:169-262.
43. Bastiaens GJH, Bousema T, Leslie T. Scale-up of malaria rapid diagnostic tests and artemisinin-based combination therapy: challenges and perspectives in sub-Saharan Africa. PLoS Med. 2014;11(1):e1001590.
44. Kasasa S, Asoala V, Gosoniu L, et al. Spatio-temporal malaria transmission patterns in Navrongo demographic surveillance site, northern Ghana. Malar J. 2013;12(1):63.
45. Murray CJ, Rosenfeld LC, Lim SS, et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012;379(9814):413-31.